Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Roflumilast-N-oxide amplifies forskolin-induced insulin release in primary islets
CAS Number: 1206161-97-8
McAleavey NM
Structure of the NDH-2 - HQNO Inhibited Complex Provides Molecular Insight Into Quinone-Binding Site Inhibitors
Nevirapine Catalog No.:M8167-2 Roflumilast-N-oxide amplifies forskolin-induced insulin releaseNevirapine is a non nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV 1 infection and AIDS. As with other antiretroviral drugs, HIV rapidly develops resistance if nevirapine is used alone, so recommended therapy consists of combinations of three or more antiretrovirals. Nevirapine in triple combination therapy has been shown to suppress viral load effectively when used as initial antiretroviral therapy (i. e., in antiretroviral
US$ 32.00
US$ 244.78
US$ 314.58